Oral Misoprostol Versus Vaginal Dinoprostone For Induction Of Labour: A Randomized Controlled Clinical Trial
NCT ID: NCT02168881
Last Updated: 2014-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
342 participants
INTERVENTIONAL
2014-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Titrated Oral Misoprostol Compared to Vaginal Dinoprostone for Induction of Labor
NCT02036437
Misoprostol Versus Dinoprostone in Induction of Labor
NCT06909721
Oral Misoprostol Solution in Comparison to Vaginal Misoprostol in Induction of Labor
NCT03863392
Oral Misoprostol Solution in Labor Induction
NCT03927807
Comparison Between Vaginal Misoprostol Gel and Oral Misoprostol Solution in Induction of Labor
NCT06874049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
misoprostol
oral misoprostol in solution 25 microgram every 2 hours
Misoprostol
dinoprostone
3 mgs dinoprostone vaginally every six hours
Dinoprostone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Misoprostol
Dinoprostone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \>37 wks
Exclusion Criteria
* Macrosomia
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwan Elkady
Dr
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams Maternity hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Marwan Osama Elkady
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ain Shams, hospital
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Kerr RS, Kumar N, Williams MJ, Cuthbert A, Aflaifel N, Haas DM, Weeks AD. Low-dose oral misoprostol for induction of labour. Cochrane Database Syst Rev. 2021 Jun 22;6(6):CD014484. doi: 10.1002/14651858.CD014484.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Misoprostol-2014
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.